Você procurou por: majelosoppressiva (Maltês - Inglês)

f’pazjenti li jkunu qed jirċievu terapija majelosoppressiva jew majeloablattiva segwita minn trapjant pbpc awtologu
in patients undergoing myelosuppressive or myeloablative therapy followed by autologous pbpc transplantation

il-kura b’filgrastim waħdu ma tipprekludix it-tromboċitopenja u l-anemija minħabba kimoterapija majelosoppressiva.
treatment with filgrastim alone does not preclude thrombocytopenia and anaemia due to myelosuppressive chemotherapy.

kura b’filgrastim waħdu ma tipprekludix l-iżvilupp ta’ tromboċitopenja u anemija assoċjat ma’ kimoterapija majelosoppressiva.
treatment with filgrastim alone does not preclude thrombocytopenia and anaemia due to myelosuppressive chemotherapy.

filgrastim għal mobilizzazzjoni tal-pbpc wara kimoterapija majelosoppressiva: filgrastim għandu jingħata permezz ta’ injezzjoni taħt il-ġilda.
filgrastim for pbpc mobilisation after myelosuppressive chemotherapy: filgrastim should be given by subcutaneous injection.

għall-mobilizzazzjoni tal-pbpc f’pazjenti li jkunu qed jirċievu terapija majelosoppressiva jew majeloablattiva segwita minn trapjant ta’ pbpc awtologi
for the mobilisation of pbpcs in patients undergoing myelosuppressive or myeloablative therapy followed by autologous pbpc transplantation

ir-rakkomandazzjonijiet tad-dożaġġ f’pazjenti pedjatriċi huma l-istess għal dawk f’adulti li qed jirċievu kimoterapija ċitotossika majelosoppressiva.
the dosage recommendations in paediatric patients are the same as those in adults receiving myelosuppressive cytotoxic chemotherapy.

ir-rakkomandazzjonijiet tad-dożaġġ f’pazjenti pedjatriċi huma l-istess bħal dawk fl-adulti li jkunu qed jirċievu kimoterapija ċitotossika majelosoppressiva.
the dosage recommendations in paediatric patients are the same as those in adults receiving myelosuppressive cytotoxic chemotherapy.

l’użu ta’ filgrastim f’pazjenti b’infezzjoni ta’ hiv iżomm l-għadd ta’ newtrofili normali sabiex jippermetti id-dożaġġ skedat tat-terapija antivirali u/jew mediċina majelosoppressiva oħra.
use of filgrastim in patients with hiv infection maintains normal neutrophil counts to allow scheduled dosing of antiviral and/or other myelosuppressive medicinal product.